Pathogenesis and Drug Development for Non-communicable Inflammatory Skin Diseases II
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 144
Special Issue Editors
Interests: pemphigus and pemphigoid diseases; complex model systems of human inflammatory skin diseases
Special Issues, Collections and Topics in MDPI journals
Interests: Autoimmune bullous diseases; pemphigus; bullous Pemphigoid; hereditary skin diseases; ichthyosis; epidermolysis bullosa hereditaria; autoimmune diseases; collagen diseases; keratinizing skin diseases
Interests: cutaneous lymphoma; psoriasis; genomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Following a very successful first edition, we are pleased to announce the launch of a second edition of this Special Issue, entitled “Pathogenesis and Drug Development for Non-Communicable Inflammatory Skin Diseases”.
Chronic, non-communicable inflammatory skin diseases, such as psoriasis, atopic dermatitis, vitiligo, pemphigus, and many more, affect up to 20% of the population. Over recent years, we have observed an unparalleled increase in the understanding of disease pathogenies. This, however, has not been implemented into clinical practice to its full potential. Thus, there is still a great and so far unmet medical need for the development of effective, safe and personalized treatments for patients suffering from chronic, non-communicable inflammatory skin diseases. To facilitate clinical translation based on pathomechanistic insights, we aim to publish reviews that summarize the state of the art in disease pathogenesis and current drug developments in the field. We will also consider highly innovative original articles and short communications.
Articles covering the following chronic, non-communicable inflammatory skin diseases are especially welcome: atopic dermatitis, psoriasis, prurigo nodularis, lichen planus, hidradenitis suppurativa, alopecia areata, vitiligo, chronic urticaria, pemphigus diseases, pemphigoid diseases, dermatitis herpetiformis, epidermolysis bullosa acquisita, dermatomyositis, systemic sclerosis, morphea, cutaneous lupus, and autoinflammatory diseases.
Please note that publication charges apply. Please feel free to contact any of the Guest Editors or the Editorial Office should you have any questions. We are looking forward to your submissions.
Prof. Dr. Takashi Hashimoto
Prof. Dr. Robert Gniadecki
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin
- inflammation
- autoimmunity
- drug discovery
- pathogenesis
